WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has established a grant program to award life science researchers more than $400,000 in RNA-interference (RNAi) reagents used to study genes in medical research and drug discovery.
